This test is most useful if any of these apply to you.
Fever, sweats and persistent fatigue after time in tick habitat can come from babesiosis as well as other infections. A Lyme test looks for a different organism. Babesia microti IgM can support a babesiosis evaluation, but a positive screen alone can't establish that parasites are currently in your blood.
Babesia microti is a parasite that infects red blood cells. The illness it causes is called babesiosis. Destruction of red blood cells can cause anemia. Anemia reduces your blood's capacity to carry oxygen. Your immune system can make IgM antibodies early in infection, followed by IgG antibodies that often persist longer. The timing overlaps, and IgM can remain detectable for months after an infection has resolved.
This test detects IgM antibodies in serum by indirect immunofluorescence (IFA). Serum is the liquid left after blood clots. The assay uses a fluorescent label to reveal antibodies that bind to parasite material on slides.
The screen reports whether antibodies are detected. A positive screen may lead to a separately reported titer. A titer describes how far a sample can be diluted before its antibody reaction disappears. The screen itself has no numerical level to trend.
Antibody testing is an established supporting tool for babesiosis. Its main limitation is distinguishing active infection from past exposure or a false-positive reaction. A blood smear looks for parasites inside red blood cells, while PCR looks for their genetic material in whole blood.
The parasite can be present before your antibody response becomes detectable. The time from a tick bite to symptoms also varies, so counting days from the bite or from the first fever doesn't provide a dependable date when an IgM result becomes conclusive. A weakened immune system can delay or reduce antibody production further.
An early study of IgM IFA in New England detected about nine in ten acute cases. That finding supports the method's diagnostic usefulness, but it doesn't establish the accuracy of every commercial screen or its performance in people without symptoms.
Research assays are trying to detect antibody responses earlier. One study using a different method to measure IgG in human serum detected six of thirteen samples that were PCR-positive but negative by conventional antibody IFA. This was an IgG research assay, so the finding doesn't describe the performance of this IgM screen.
Antibodies can outlast the infection that triggered them. IgM positivity therefore suggests a possible recent response without reliably dating the infection. Studies of IgG and total antibodies have found positivity lasting a year or longer, but those measurements aren't interchangeable with IgM.
Parasites can also persist after symptoms improve. In a follow-up study of 84 antibody-positive blood donors, some had evidence of low-level infection that appeared intermittently during follow-up. The study used broader antibody testing and several methods of detecting parasites; it did not establish an IgM timeline.
PCR needs context too. After treatment, parasite DNA can remain detectable even when someone has recovered, so a positive PCR by itself does not always mean treatment failed. Antibody positivity, symptoms and parasite detection can resolve at different times.
Babesiosis ranges from an infection you never notice to severe illness. Older adults, people without a working spleen, and people with impaired immunity are more likely to have complications. Cancer, advanced HIV infection and treatments such as rituximab can increase that risk.
A multicenter study of 225 people with babesiosis found more hospitalizations, complications and recurrences among those who were immunocompromised or had an absent or poorly functioning spleen. A separate hospital study linked breathing difficulties and abnormal chest X-rays with severe disease. These findings concern confirmed babesiosis; an IgM result does not predict how severe your illness will be.
Someone who feels well can still carry parasites that can be transmitted through donated blood. In an investigational study of 15,000 donations from areas with different exposure risks, about 1% of samples from the high-risk area were repeatedly reactive on a combined IgG/IgM antibody assay. That percentage was not the rate of active infection or positivity on this IgM screen.
A larger study screened 89,153 donations using antibody testing and PCR and found an association with fewer transfusion-transmitted infections. Current U.S. screening in designated risk areas uses specialized tests for parasite genetic material. A personal IgM screen serves a different purpose from the blood center's donation screening.
The ticks that transmit Lyme disease can also transmit Babesia microti and anaplasmosis. Having antibodies to more than one organism can reflect exposure at different times. It doesn't establish that both infections are active together.
The studies below used different antibody measurements, sometimes tested for different Babesia species, and selected different populations. Their results describe exposure patterns within those groups.
| Who Was Studied | What Was Measured | What They Found |
|---|---|---|
| 283 people in southern Sweden, including a group with Lyme antibodies and healthy controls | IgG to B. microti or B. divergens. Testing used serum in the Lyme-antibody group and plasma in controls. | Babesia IgG was more than six times as common in the Lyme-antibody group: 16.3% versus 2.5%. |
| 130 people in New York undergoing Lyme antibody testing, including negative results | Both IgM and IgG to B. microti in serum by IFA | About one in four had both antibodies; this did not establish active babesiosis. |
| 135 people with available follow-up serum from a Norwegian study of 188 people with a Lyme rash | B. microti IgG in serum by IFA | No B. microti IgG was detected. |
Persistent fever during Lyme treatment or blood tests showing anemia or low platelets give a stronger reason to investigate another tick-borne infection than a positive Lyme antibody result alone. Lingering fatigue has several possible causes and doesn't establish babesiosis.
Babesia Microti Antibody IgM Screen is best interpreted alongside these tests.
Babesia Microti Antibody IgM Screen is included in these pre-built panels.
See whether your body has met the blood parasite behind babesiosis, and whether that encounter looks recent or long past.